Tirzepatide
What Is Tirepatide
TIRZEPATIDE, also known as (MOUNJARO), is GLP-1(Glucagon-Like Peptide-1) plus GIP(Glucose dependent Insulinotropic Polypeptide) medication recently approved by the FDA for effective and long-term weight management.
How Does Tirzepatide work?
Who can use Tirzepatide?
Anyone with BMI > 30, or other health conditions related to increased weight (HTN, high cholesterol, PCOS)
What are some Side Effects of Tirzepatide?
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Constipation
- Upset stomach
Benefits of Tirzepatide
- Weight reduction by up to 20-25%
- Improves Fat/Lipid metabolism
- Reduces Glycemic levels or Hgba1c Level
- Improves Insulin Sensitivity
Why Should I Choose TIZEPATIDE for Weight Loss?
- Tirzepatide is the first and only approved single medication that activates GIP and GLP-1 receptors in the body.
- Tirzepatide provides superior Hgb A1C reduction across all clinical trials compared to other medications.
- Increased average weight loss across all clinical trials.